Oppenheimer analyst Steven M. Lichtman upgraded AngioDynamics (NASDAQ: ANGO) from Perform to Outperform with a price target of $12.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades

AngioDynamics (ANGO) Misses Q3 EPS by 2cApril 4, 2024 7:36 AM Form 8-K ANGIODYNAMICS INC For: Apr 04April 4, 2024 7:32 AM AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureApril 4, 2024 7:00 AM AngioDynamics (ANGO) Receives 510(k) Clearance for AlphaVac F18 SystemApril 4, 2024 6:45 AM AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PEApril 4, 2024 6:45 AM